Overview of studies in systematic review, grouped according to study-design and indication: regimens, population size, treatment duration and summary of main outcome data and conclusions.

GRADE level of evidence per category is added. INI-containing treatment arms are underlined. (c)ART = (combination) antiretroviral treatment; INI = integrase inhibitor; CTR = control arm; (w) = weeks; VL<50 = viral load or HIV RNA <50 copies/ml; N = not applicable; RAL = raltegravir; EFV = efavirenz; EVG = elvitegravir; COBI = cobicistat; DTG = dolutegravir; ATV = atazanavir; DRV = darunavir; TDF/FTC = tenofovir/emtricitabine; ABC/3TC = abacavir/lamivudine; LPV = lopinavir; r = ritonavir; (N)NRTI = (non-)nucleoside reverse transcriptase inhibitor; PI = protease inhibitor; BR = background regimen; T20 = enfurvirtide; NVP = nevirapin; HIBC = hyperimmune bovine colostrum.